U.S. stocks faced pressure Thursday amid news involving Nvidia CEO Jensen Huang, but several companies moved higher. Eli Lilly closed at a record, Labcorp reached an intraday high and nine stocks qualified for the latest selection list. Nvidia fell sharply, while Arista Networks gained 5%, underscoring the divergence between individual stocks and sectors.
Eli Lilly closes at a record; Labcorp hits an intraday high
Eli Lilly, known for its GLP-1 products, finished Thursday at a record closing price. Labcorp, a medical testing company, also touched a record during the session. The moves came as attention shifted toward healthcare stocks, though no specific catalysts or percentage gains were provided for either company.
Veralto reaches a high as Arista gains 5%
Veralto, which makes pollution-control equipment and provides related services, also touched a record high. Arista Networks, an AI cloud-networking company, rose 5%, in contrast with Nvidia’s sharp decline. Nvidia was under pressure amid news involving its CEO, but details of the developments and the chipmaker’s percentage drop were not specified.
Oil and gas transport company Okeanis Eco rose 2.2%. The move was linked to continued tightness in oil supply, though no supply or oil-price figures were given.
Nine stocks qualify for the selection list
Nine stocks met the criteria for inclusion Thursday. The five companies identified were Eli Lilly, Labcorp, Veralto, Arista Networks and Okeanis Eco. The screening system is updated regularly, adding stocks to watch and removing those whose performance begins to weaken. Its criteria focus on characteristics often seen in stocks during the early stages of a substantial advance.
The selections span categories including IBD 50, Sector Leaders and IBD Big Cap 20. They offer a way to track stock performance and changes to the lists, rather than a forecast of future prices. Thursday’s session featured record highs in healthcare, a steep decline in Nvidia and gains in some technology and energy-transport stocks.